Search for Nurse Practitioner Events

The most comprehensive directory of national, statewide and local nurse practitioner events

Clinical Challenges and Emerging Therapies in IBD - Chicago, IL

The Gwen, a Luxury Collection Hotel, Michigan Avenue Chicago
521 North Rush Street
Chicago, IL 60611

Saturday, July 21, 2018 at 8:00am CT - 5:00pm CT

The Gwen, a Luxury Collection Hotel, Michigan Avenue Chicago
521 North Rush Street
Chicago, IL 60611

Info

Topic

Current IBD clinical challenges, emerging therapies, and case-based discussions on what a clinician should do #Gastroenterology

Speaker(s)

David T. Rubin, MD, FACG; Aline Charabaty, MD; Russell D. Cohen, MD, FACG; Jean-Frederic Colombel, MD; Raymond K. Cross, Jr., MD, MS; Sushila Dalal, MD; Stephen B. Hanauer, MD, FACG; David P. Hudesman, MD, NYU; Jennifer Labas, RN, MSN, FNP-BC

CE Credits

This event offers 6.5 CME credits to attendees.
CE accredited by Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education.

Interested In Attending This Event?

Additional Registration Information:

One Day IBD Event For NPs and HCPs who treat IBD

See Faculty and Agenda: http://clinicalchallengesinibd.com

CME: 6.5*

Cost: Only $129

Clinical Challenges and Emerging Therapies in IBD is a one-day event designed for clinicians involved in the therapeutic management of patients with inflammatory bowel diseases. Moderated by David T. Rubin, MD, FACG, AGAF, this one-day event will include four interactive sessions.

Who Should Attend

This educational activity is specifically designed for NP's and other healthcare professionals involved and/or interested in the therapeutic management of patients with IBD.


Objectives

After successful completion of this activity, participants should be able to:

  • Assess the mechanism of action and therapeutic potential of evolving treatments in IBD
  • Evaluate strategies for sequencing therapeutics in the era of biologics, immunotherapies and biosimilars
  • Identify a personalized therapeutic approach to optimally manage complex cases of CD
  • Interpret pivotal clinical trial data and novel management strategies for integration into clinical practice
  • Describe therapeutic strategies designed to prevent infections and extraintestinal manifestations in IBD
  • Define the role of treat-to-target in IBD regimens designed to maximize the opportunity to achieve remission and avoid relapse
  • Identify strategies to de-escalate therapy once remission is achieved in IBD
  • Assess the emerging role of biosimilars in IBD therapy, and their integration into current standards of care

*In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Imedex. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.